Sumi Shrishrimal I Rhythm Technologies, Inc. (IRTC) insider trading activity

Sumi Shrishrimal is EVP, Chief Risk Officer of iRhythm Technologies, Inc.. Currently has a direct ownership of 34,685 shares of IRTC, which is worth approximately $4.71 Million. The most recent transaction as insider was on Jun 02, 2025, when has been sold 1,608 shares (Common Stock) at a price of $140.21 per share, resulting in proceeds of $225,457. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.7K

3.96% 3M change

48.88% 12M change

Total Value Held $4.71 Million

Sumi Shrishrimal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2025	SELL Open market or private sale	$225,457 $140.21 p/Share	1,608 Reduced 4.43%	34,685 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$12,576 $71.46 p/Share	176 Added 0.48%	36,293 Common Stock
Mar 03 2025	SELL Open market or private sale	$187,737 $108.77 p/Share	1,726 Reduced 4.56%	36,117 Common Stock
Feb 26 2025	SELL Open market or private sale	$890,536 $112.13 p/Share	7,942 Reduced 17.35%	37,843 Common Stock
Feb 26 2025	BUY Grant, award, or other acquisition	-	6,732 Added 12.82%	45,785 Common Stock
Feb 25 2025	BUY Grant, award, or other acquisition	-	15,293 Added 28.14%	39,053 Common Stock
Nov 29 2024	BUY Other acquisition or disposition	$7,860 $71.46 p/Share	110 Added 0.46%	23,760 Common Stock
Jun 03 2024	SELL Open market or private sale	$100,557 $88.91 p/Share	1,131 Reduced 4.63%	23,298 Common Stock
May 31 2024	BUY Other acquisition or disposition	$13,946 $74.98 p/Share	186 Added 0.78%	23,650 Common Stock
Mar 04 2024	SELL Open market or private sale	$80,354 $111.14 p/Share	723 Reduced 2.87%	24,429 Common Stock
Feb 28 2024	BUY Grant, award, or other acquisition	-	6,445 Added 20.4%	25,152 Common Stock
Nov 30 2023	BUY Other acquisition or disposition	$12,033 $72.49 p/Share	166 Added 0.7%	23,464 Common Stock
Jun 02 2023	SELL Open market or private sale	$123,598 $111.45 p/Share	1,109 Reduced 5.6%	18,707 Common Stock
Feb 27 2023	BUY Grant, award, or other acquisition	-	6,961 Added 26.12%	19,687 Common Stock

Also insider at

DXCM

DEXCOM INC Healthcare

SVP Chief Risk Officer